Back to Search
Start Over
Composition of TWIST1 dimers regulates fibroblast activation and tissue fibrosis.
- Source :
-
Annals of the rheumatic diseases [Ann Rheum Dis] 2017 Jan; Vol. 76 (1), pp. 244-251. Date of Electronic Publication: 2016 Apr 25. - Publication Year :
- 2017
-
Abstract
- Objectives: TWIST1 is a member of the class B of basic helix-loop-helix transcription factors that regulates cell lineage determination and differentiation and has been implicated in epithelial-to-mesenchymal transition. Here, we aimed to investigate the role of TWIST1 for the activation of resident fibroblasts in systemic sclerosis (SSc).<br />Methods: The expression of Twist1 in fibroblasts was modulated by forced overexpression or siRNA-mediated knockdown. Interaction of Twist1, E12 and inhibitor Of differentiation (Id) was analysed by co-immunoprecipitation. The role of Twist1 in vivo was evaluated using inducible, conditional knockout mice with either ubiquitous or fibroblast-specific depletion of Twist1. Mice were either challenged with bleomycin or overexpressing a constitutively active transforming growth factor (TGF)β receptor I.<br />Result: The expression of TWIST1 was increased in fibroblasts in fibrotic human and murine skin in a TGFβ/SMAD3-dependent manner. TWIST1 in turn enhanced TGFβ-induced fibroblast activation in a p38-dependent manner. The stimulatory effects of TWIST1 on resident fibroblasts were mediated by TWIST1 homodimers. TGFβ promotes the formation of TWIST1 homodimers by upregulation of TWIST1 and by induction of inhibitor of DNA-binding proteins, which have high affinity for E12/E47 and compete against TWIST1 for E12/E47 binding. Mice with selective depletion of Twist1 in fibroblasts are protected from experimental skin fibrosis in different murine models to a comparable degree as mice with ubiquitous depletion of Twist1.<br />Conclusions: Our data identify TWIST1 as a central pro-fibrotic factor in SSc, which facilitates fibroblast activation by amplifying TGFβ signalling. Targeting of TWIST1 may thus be a novel approach to normalise aberrant TGFβ signalling in SSc.<br /> (Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.)
- Subjects :
- Animals
Case-Control Studies
Female
Fibroblasts drug effects
Gene Expression Regulation drug effects
Gene Expression Regulation physiology
Gene Knockdown Techniques
Humans
Male
Mice, Knockout
Nuclear Proteins biosynthesis
Nuclear Proteins deficiency
Nuclear Proteins genetics
Nuclear Proteins metabolism
Protein Multimerization physiology
RNA, Messenger genetics
RNA, Small Interfering genetics
Scleroderma, Systemic pathology
Signal Transduction physiology
Skin pathology
Transforming Growth Factor beta pharmacology
Twist-Related Protein 1 biosynthesis
Twist-Related Protein 1 deficiency
Twist-Related Protein 1 genetics
Twist-Related Protein 1 metabolism
Fibroblasts metabolism
Nuclear Proteins physiology
Scleroderma, Systemic metabolism
Twist-Related Protein 1 physiology
Subjects
Details
- Language :
- English
- ISSN :
- 1468-2060
- Volume :
- 76
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Annals of the rheumatic diseases
- Publication Type :
- Academic Journal
- Accession number :
- 27113414
- Full Text :
- https://doi.org/10.1136/annrheumdis-2015-208470